Inā kiʻekiʻe a haʻahaʻa paha ka waiwai pH o ka peptide, ʻāhuehue, gelation, puhi ana, a e hiki mai ana ke kani. ʻO ka ʻōlelo maʻamau, Hiki ke hoʻoponopono ʻia kēia mau mea e nā mea hoʻoheheʻe buffer. No ka nui o nā peptides, me ka hoʻohana ʻana i nā mea hoʻoheheʻe buffer e hoʻoponopono i ka waiwai pH paʻa. Pono nā peptides kūikawā e noʻonoʻo i nā hoʻolālā optimization ma ke ʻano o nā paʻakai a i ʻole nā hoʻololi.
1. Ka hopena o ka pH i nā lāʻau lapaʻau
Hōʻike nui ʻia ka hopena o ka pH i nā lāʻau lapaʻau i ka lawe ʻana i ka lāʻau, lākiō lāʻau, a me ka hoopau ana i ka laau.
1. ʻO ka ʻai ʻana i ka lāʻau: ʻO ka hopena o ka pH i ka lawe ʻana i ka lāʻau i hōʻike nui ʻia i ka absorption gastrointestinal a me ka reabsorption renal..
Ma ke ʻano o ka absorption gastrointestinal, hiki i kekahi mau lāʻau ke hoʻololi i ka waiwai pH ma ka ʻōpū o ka ʻōpū, e pili ana i ka lawe ʻana a me ka hoʻohana ʻana i nā lāʻau lapaʻau. E pili ana i ka reabsorption renal, different pH values of urine will affect the excretion and reabsorption of drugs.
2. Drug compatibility: pH also has an important influence on drug compatibility. Some drugs are unstable at specific pH values and are prone to decomposition or chemical reactions.
3. Drug excretion: pH also affects the excretion process of drugs. ʻo kahi laʻana, alkalinizing urine can promote the renal metabolism of certain acidic drugs, thereby improving the therapeutic effect of diseases such as urinary tract infections.
2. The effect of pH on polypeptides
The effect of pH on polypeptides is mainly reflected in the effect of environmental conditions on polypeptide folding and stability.
The structural stability of polypeptides is mainly determined by two aspects: one is the sequence and secondary structure of the peptide chain itself, a ʻo kekahi, ʻo ia ke kūlana kino a me ke kemika o ke kaiapuni hope.
Hiki i nā loli i ka pH ke hoʻopili pololei i ka hoʻonohonoho spatial a me ka hana o nā polypeptides, a pēlā e pili ai i ko lākou kūpaʻa. I loko o kahi ʻano alkaline, hiki i kekahi mau polypeptides ke hana i nā paʻakikī me nā mea ʻē aʻe, a hiki i keia hale ke hoololi i ke ano o ka polypeptides, e pili ana i ka hana o nā lāʻau polypeptide.
ʻO ka hoʻolālā lua he conformation kikoʻī i hoʻokumu ʻia e nā ʻātoma iwi kuamoʻo o ke kaulahao nui polypeptide e hoʻopuni ana a i ʻole ka pelu ʻana ma kekahi axis., ʻo ia, ka hoʻonohonoho kūlana spatial o nā ʻātoma iwi kuamoʻo o ke kaulahao polypeptide, me ka hoʻokomo ʻole ʻana i nā kaulahao ʻaoʻao o nā koena amino acid.
Inā ʻaʻole mālama ʻia ka waiwai pH i loko o kahi ākea kūpono, e hāʻule paha kekahi mau pūʻulu pale peptide, hiki ke luku ʻia ka hale lua, a hiki ke hoʻemi ʻia a hoʻopau ʻia paha kāna hana. Pono kēlā me kēia peptide e hoʻoholo i ka maikaʻi o kāna waiwai pH ke hoʻoponopono ʻia i nā kūlana kūʻokoʻa. Hiki ke kuhikuhi ʻia ka laulā o nā kūlana kūʻokoʻa i ka ʻikepili aʻe:
· ʻO ka waiwai pH o ka wai maʻemaʻe: 6.5-8.5.
· ʻO ka waiwai pH o ka paʻakai physiological: 7-7.5.
Hiki i ka hiki ʻana i kēia laulima ke pale maikaʻi i nā hopena he nui i ka wā o ka hoʻokolohua.
Pono e hoʻomaopopo ʻia no kekahi mau peptides kikoʻī, hiki i ka waiwai pH ke kumu i ka ua ma lalo o nā kūlana kū ʻole, ʻaʻole hiki ke hoʻoheheʻe ʻia i ka wai sterile, he mea e ae.
Hoʻoholo
1. I ka synthesizing peptides, ua hoʻoholo ʻia e hoʻololi i ka hoʻolālā optimization ma ke ʻano paʻakai e hoʻonā i nā pilikia o ka gelation, ʻāhuehue, puhi ana, ke kuʻi ʻana, etc. ma muli o ka waiwai pH, no laila e manaʻo ʻia e hiki i nā peptides i kēia manawa e hoʻomohala ʻia i ka pae pH kūpono. He kūpono kēia, akā ʻaʻole kūpono i nā huahana a pau, akā, he manaʻo maikaʻi loa ia.
2. Ma o ka hoʻoponopono ʻana i ka solvent buffer, i ka wā ʻakika ka mea hoʻonā hoʻokolohua, Hiki ke noʻonoʻo ʻia ka sodium citrate; paʻakai paʻakai, ina he alkaline, Hiki ke hoʻohana ʻia ka waikawa citric.
Bingyan Gao
Pilikino: ʻO Bingyan Gao ka "puka kiaʻi hope" o ka maʻemaʻe peptide a me ka maikaʻi. Maikaʻi ʻo ia i ka hoʻohana ʻana i nā mea analytical kiʻekiʻe kiʻekiʻe a loea i ka hoʻomohala ʻana i nā ʻano hoʻokaʻawale chromatographic maʻamau no nā peptides hoʻololi paʻakikī.. Ua hoʻokumu ʻo ia i kahi ʻōnaehana hoʻomaʻemaʻe pono ʻole e hōʻoia i ka maʻemaʻe o ka huahana 99% a i ʻole kiʻekiʻe aʻe akā ʻike pono a hoʻopau i nā ʻano haumia i hiki ke hoʻoulu i ka immunogenicity. Me ka hoʻomaopopo hohonu ʻana i nā koi hoʻoponopono FDA a me EMA no nā lāʻau peptide, hōʻoia ʻo ia ʻo kēlā me kēia pūʻulu i hoʻokuʻu ʻia mai ka hale hana e hele pū ʻia me kahi palapala hōʻoia o ka ʻike ʻana (COA).
- Documenting Peptide Storage Temperatures — Records for Independent Laboratory Review 2026年11月22日
- A Peptide Procurement Brief — Separating Prescribed Injections from Research Reagents 2026年11月22日
- P Means Proline — Wehewehe Notation, Nā Kiʻekiʻe Chromatographic, a me ke koena nui 2026年11月21日
- Nā Kiʻi Akina Amino a me ka Papa Manawa — Codes, Waiwai, a me nā Hapa Māhele 2026年11月20日
- Ke hoʻohana nei i nā papa waiwai amino acid - hoʻohālikelike i ka lawelawe ʻana i nā hoʻololi me kahi ʻano like ʻole 2026年11月20日
ʻO kā mākou Kaʻina Hana Hōʻoiaʻiʻo
Manaʻo mākou i ka pololei a me ka pololei i kā mākou ʻike. Eia kā mākou e mālama ai i nā kūlana kiʻekiʻe:
- Ka Manaʻo Manaʻo: Hoʻoponopono ʻia nā ʻatikala a pau e nā loea kumuhana.
- Hōʻoia Puna: Kākoʻo ʻia ka ʻike e ka hilinaʻi, nā kumu hou.
- ʻAlohilohi: Hōʻike maopopo mākou i nā kuhikuhi a hōʻike i nā paio kūpono.
Ko makou Papa Nana
Nānā maikaʻi ʻia kā mākou ʻike e nā poʻe loea ʻike e hōʻoia i ka pololei a me ka pili.
- Ka poe akamai: ʻIke ʻia kēlā me kēia ʻatikala e nā loea me ka ʻike kikoʻī.
- Nā ʻike hou loa: Hoʻokomo mākou i ka noiʻi hou loa, nā ʻano, a me nā kūlana.
- Hoʻoholo i ka maikaʻi: Hoʻomaopopo ka poʻe loiloi i ka maopopo, pololei, a me ka piha.
E ʻimi i ka lepili loiloi loea e heluhelu ai i ka ʻike hiki iā ʻoe ke hilinaʻi.
